Nanotechnology applications for the therapy of liver fibrosis

doi:10.3748/wjg.v20.i23.7242

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 23

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9765)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

807

WORD

375

HTML

7001

Figures (1-3)

422

Sum=8605

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

585

Download

574

Sum=1159

Jun 21, 2014 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (74)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 21, 2014; 20(23): 7242-7251
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7242

Nanotechnology applications for the therapy of liver fibrosis

Lydia Giannitrapani, Maurizio Soresi, Maria Luisa Bondì, Giuseppe Montalto, Melchiorre Cervello

Lydia Giannitrapani, Maurizio Soresi, Giuseppe Montalto, Unit of Internal Medicine, Biomedical Department of Internal Medicine and Specialties DiBiMIS, University of Palermo, 90127 Palermo, Italy

Maria Luisa Bondì, Institute for Nanostructured Materials Studies, National Research Council (CNR), 90146 Palermo, Italy

Giuseppe Montalto, Melchiorre Cervello, Institute of Biomedicine and Molecular Immunology “A. Monroy”, National Research Council (CNR), 90146 Palermo, Italy

Author contributions: Giannitrapani L and Cervello M collected and analyzed literature data; Soresi M contributed analytics tools; Bondì ML and Montalto G supervised the paper; Giannitrapani L and Cervello M wrote the paper.

Supported by Grants from the Italian Ministero dell’Istruzione, dell’Università e della Ricerca (Ministry for Education, Universities and Research), MIUR FIRB-MERIT n. RBNE08YYBM to Cervello M, Montalto G and Bondì ML

Correspondence to: Lydia Giannitrapani, MD, PhD, Unit of Internal Medicine, Biomedical Department of Internal Medicine and Specialties DiBiMIS, University of Palermo, Via del Vespro 141, 90127 Palermo, Italy. lydiagiannitp@gmail.com

Telephone: +39-91-6552916 Fax: +39-91-6552977

Received: November 12, 2013
Revised: January 16, 2014
Accepted: March 6, 2014
Published online: June 21, 2014
Processing time: 220 Days and 16.5 Hours

Core Tip

Core tip: New drugs or new drug delivery strategies to cure liver fibrosis are needed to find effective therapeutic options for this pathologic condition. Therapies based on nanotechnologies have emerged as an innovative and promising alternative to conventional therapies. This work aims to review the most recent literature about the use of nanotechnology approaches to reduce liver fibrosis.